Influenza News and Research

Latest Influenza News and Research

Alnylam, Mount Sinai scientists discover svRNAs that play a critical role in influenza A virus replication

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by Alnylam scientists and collaborators from Mount Sinai School of Medicine. In the new study, Alnylam and Mount Sinai scientists discovered a novel class of virus-produced small non-coding RNAs, called small viral RNAs (svRNAs), which play a critical role in the replication of influenza A virus.

2 Jun 2010

Anti-Dengue drug candidates demonstrate efficacy in preliminary cell culture studies

NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant efficacy in the recently completed preliminary cell culture studies. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.

2 Jun 2010

Plans to continue flu vaccination ban – intensive investigations ongoing

In the first quarter of this year nearly 300 children across Australia fell ill with fevers, vomiting and convulsions following administration of the seasonal flu vaccine.

2 Jun 2010

BioCryst to commence Phase 2 study of BCX4208 alone and in combination with allopurinol in gout patients

BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.

1 Jun 2010

AAPA recognizes role of PAs in transforming health care delivery with 2010 PAragon Awards

The American Academy of Physician Assistants celebrated the role of physician assistants in transforming health care delivery at its 38th Annual Physician Assistant Conference in Atlanta yesterday with its presentation of the 2010 PAragon Awards.

1 Jun 2010

Mucosis receives € 3M innovation credit line from Dutch Ministry for development of FluGEM influenza vaccine

Dutch vaccine development company Mucosis B.V. announced today that it has received an innovation credit line of approximately € 3 million from Agentschap NL, an agency of the Dutch Ministry of Economic Affairs. Mucosis will use this loan towards the clinical development of its lead product FluGEM™, an influenza vaccine that can be administered by a simple spray in the nose. The loan will be redeemed only if the FluGEM™ clinical development program is concluded successfully.

31 May 2010

St. Jude Garden provides fresh produce to patients, staff

Harvesting fruits, vegetables and herbs at the peak of freshness is a recipe for good taste, but it also offers higher nutritional value which is important to the patients and staff at St. Jude Children's Research Hospital.

29 May 2010

Research roundup: Reform's impact on health spending; Cultural/Racial differences in medicine; Swine flu lessons

The Impact Of Health Reform On Health Spending - This issue brief "projects the effect of national reform on total national health expenditures and the insurance premiums that American families would likely pay. We estimate that, on net, the combination of provisions in the new law will reduce health care spending by $590 billion over 2010-2019 and lower premiums by nearly $2,000 per family.

29 May 2010

Allergic reactions prevent people with allergic asthma from generating healthy immune response to influenza

New research from UT Southwestern Medical Center suggests that allergic reactions to pet dander, dust mites and mold may prevent people with allergic asthma from generating a healthy immune response to respiratory viruses such as influenza.

29 May 2010

Previous recommendations on H1N1 pandemic influenza vaccine still stand: SAGE

Previous recommendations on who should be vaccinated with the H1N1 pandemic influenza vaccine still stand according to the World WHO's Strategic Advisory Group of Experts on Immunization, the principal advisory group to WHO for development of policy related to vaccines and immunization.

28 May 2010

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today issued its Interim Management Statement covering the period January 1, 2010, to March 31, 2010.

28 May 2010

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announced its Final Results for the year ending December 31, 2009, and the availability of its 2009 annual report on its website.

28 May 2010

Effective infant vaccination against pneumonia needed in sub-Saharan Africa

Researchers at the University of Warwick, and the Kenya Medical Research Institute, Kilifi, Kenya, have found that respiratory syncytial virus (RSV) appears to be the predominant virus detected among infants and children hospitalized in Kenya with severe pneumonia, according to a study in the May 26 issue of JAMA. The contribution to this severe disease by an individual pathogen stresses the need for effective infant vaccination.

28 May 2010

Not all strains of influenza die off at the end of winter, reveals genetic analysis

Every autumn, as predictably as falling leaves, flu season descends upon us. Every spring, just as predictably, the season comes to a close. This cyclical pattern, common in temperate regions, is well known, but the driving forces behind it have been in question.

28 May 2010

Researchers study safety and immunogenicity of two H1N1 vaccines in UK children

The first head to head study of the two H1N1 vaccines used in the UK during the recent pandemic finds that the adjuvanted split virus vaccine induced higher immune response rates in young children, but was associated with more reactions than the whole virus vaccine.

28 May 2010

Fear of H1N1 appears to be the driving factor behind adoption of preventive behaviors: Study

Fear of the H1N1 virus appears to be the driving factor behind the adoption of preventive behaviors, according to a study published in the June issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

27 May 2010

A step closer to a universal influenza virus vaccine

Researchers at Mount Sinai School of Medicine have developed a new influenza vaccine that brings science one step closer to a universal influenza vaccine that would eliminate the need for seasonal flu shots. The new findings can be found in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.

26 May 2010

RSV appears to be predominant among Kenyan children hospitalized with severe pneumonia: Study

Among infants and children hospitalized in Kenya with severe pneumonia, respiratory syncytial virus appears to be the predominant virus detected, according to a study in the May 26 issue of JAMA.

26 May 2010

Workplace wellness programs improve employer's bottom line

"Who has time?" is a frequent question in response to the suggestion of a medical check-up. Job demands aren't becoming easier to meet in this challenging economy. And there is always a "to-do" list waiting at home. Naturally employees feel these pressures.

26 May 2010

Researchers determine critical role of bone marrow cells in fighting respiratory viruses

Researchers at Mount Sinai School of Medicine for the first time have determined that bone marrow cells play a critical role in fighting respiratory viruses, making the bone marrow a potential therapeutic target, especially in people with compromised immune systems. They have found that during infections of the respiratory tract, cells produced by the bone marrow are instructed by proteins to migrate to the lungs to help fight infection. The data are published in the current issue of Cell Host & Microbe.

25 May 2010

Influenza News and Research

Latest Influenza News and Research

Alnylam, Mount Sinai scientists discover svRNAs that play a critical role in influenza A virus replication

Anti-Dengue drug candidates demonstrate efficacy in preliminary cell culture studies

Plans to continue flu vaccination ban – intensive investigations ongoing

BioCryst to commence Phase 2 study of BCX4208 alone and in combination with allopurinol in gout patients

AAPA recognizes role of PAs in transforming health care delivery with 2010 PAragon Awards

Mucosis receives € 3M innovation credit line from Dutch Ministry for development of FluGEM influenza vaccine

St. Jude Garden provides fresh produce to patients, staff

Research roundup: Reform's impact on health spending; Cultural/Racial differences in medicine; Swine flu lessons

Allergic reactions prevent people with allergic asthma from generating healthy immune response to influenza

Previous recommendations on H1N1 pandemic influenza vaccine still stand: SAGE

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

Effective infant vaccination against pneumonia needed in sub-Saharan Africa

Not all strains of influenza die off at the end of winter, reveals genetic analysis

Researchers study safety and immunogenicity of two H1N1 vaccines in UK children

Fear of H1N1 appears to be the driving factor behind adoption of preventive behaviors: Study

A step closer to a universal influenza virus vaccine

RSV appears to be predominant among Kenyan children hospitalized with severe pneumonia: Study

Workplace wellness programs improve employer's bottom line

Researchers determine critical role of bone marrow cells in fighting respiratory viruses

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in